INDV
Indivior Pharmaceuticals Inc- Healthcare
- Drug Manufacturers - Specialty & Generic
- $4.30B market cap
Forecast run · Sep 14, 2026Upside rank 2413 of 3,136
Model Signal
ForecastQ Daily Probabilities
17.5%
17.1%
5.4%
Analyst Consensus
Recommendation2.00/5 Buy
Last price$34.49
Price target$48.00
Implied move+39.2%
Analysts4
ForecastQ Portfolios
INDV is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.
Company Profile
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.